Kodiak Sciences Inc (KOD NASDAQ) stock market data APIs
$24.3065
0.08(0.3%)
as of December 5, 2025
Try our APIs with
free plan!
Kodiak Sciences Inc Financial Data Overview
Price chart is built with
Anychart
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor (VEGF) antibody biopolymer that has complete Phase 3 clinical study to treat high prevalence retinal vascular diseases; and in Phase 3 clinical study for the treatment of diabetic retinopathy, wet age-related macular degeneration (AMD), retinal vein occlusion, and diabetic macular edema, as well as in Phase 2/3 clinical study to treat wet AMD. The company's preclinical stage product candidate includes KSI-501, an anti- interleukin-6 (IL-6) and VEGF-trap bispecific antibody biopolymer conjugate for high prevalence retinal vascular diseases; and KSI-101 (KSI-501P), an unconjugated bispecific protein targeting IL-6 and VEGF developed for patients who have retinal fluid and inflammation. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.
Prev. Close
24.3065
Open
24.3882
High
25.177
Low
23.715
52 wk Range
1.92-24.99
Market Cap
1 313 M
Shares Outstanding
53 048 K
EPS
-1.16
Beta
2.713
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Kodiak Sciences Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Kodiak Sciences Inc data using free add-ons & libraries
Get Kodiak Sciences Inc Fundamental Data
Kodiak Sciences Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -204 704 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-12
- EPS/Forecast: -1.02
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Kodiak Sciences Inc News
New
Kodiak Q3 Loss Wider Than Expected, Pipeline Development in Focus
Kodiak Sciences KOD reported a loss of $1.16 per share in the third quarter of 2025, wider than the Zacks Consensus Estimate of a loss of $1.07. The company had incurred a loss of 84 cents per share i...
Stocks Settle Mostly Higher on Government Reopening Optimism
The S&P 500 Index ($SPX) (SPY) on Tuesday closed up +0.21%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up +1.18%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -0.31%. December E-...
Stocks Settle Mostly Higher on Government Reopening Optimism
The S&P 500 Index ($SPX) (SPY) on Tuesday closed up +0.21%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up +1.18%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -0.31%. December E-...
Sector Update: Health Care Stocks Gain Late Afternoon
Health care stocks rose late Tuesday afternoon, with the NYSE Health Care Index adding 2.4% and the PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscrip...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
